From IT to Biotech: Sujal Patel Discusses the Promise of the Proteome on “Close to the Edge”

Nautilus is developing a large-scale, single-molecule proteomic analysis technology designed to achieve quantification of >95% of the proteome, in the process delivering extreme sensitivity and scale. Nautilus has set a goal of commercializing its platform by late 2023, with several key internal milestones met across a range of platform design and science activities . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge

Previous articleMerck & Co. to Acquire Acceleron for $11.5B
Next articleCuriox Joins NIST Flow Cytometry Standards Consortium